AMRX

시간 외 거래: 17.50

Amneal Pharmaceuticals Inc (AMRX)

개요 뉴스 가격 이력 옵션 체인 토론 예측

Relative Volume:

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Amneal Pharmaceuticals Inc

Healthcare (1088)

908-947-3120

400 Crossing Boulevard, 3rd Floor, Bridgewater

@amnealpharma

최신 SEC 제출 서류

AMRX's Discussions on Twitter

Compare AMRX vs TAK, HLN, TEVA, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AMRX Amneal Pharmaceuticals Inc	17.50	5.70B	3.05B	181.32M	186.11M	0.373
TAK Takeda Pharmaceutical Co Adr	17.05	54.77B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.04	44.48B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.00	37.30B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.20	32.10B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	529.34	22.74B	3.17B	1.29B	1.01B	27.09

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-04-17	개시	UBS	Buy
2025-12-09	개시	Barclays	Overweight
2025-06-06	개시	Goldman	Buy
2025-02-24	업그레이드	JP Morgan	Neutral → Overweight
2024-09-06	업그레이드	JP Morgan	Underweight → Neutral
2021-04-07	재개	RBC Capital Mkts	Sector Perform
2021-03-08	업그레이드	Goldman	Sell → Buy
2020-12-14	업그레이드	Barclays	Equal Weight → Overweight
2020-12-14	업그레이드	Guggenheim	Neutral → Buy
2020-07-27	개시	Goldman	Sell
2020-05-12	업그레이드	Guggenheim	Sell → Neutral
2019-12-12	다운그레이드	Raymond James	Outperform → Mkt Perform
2019-11-12	다운그레이드	JP Morgan	Neutral → Underweight
2019-11-07	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2019-07-22	업그레이드	SVB Leerink	Mkt Perform → Outperform
2019-07-11	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	업그레이드	Piper Jaffray	Neutral → Overweight
2019-06-11	개시	Barclays	Equal Weight
2019-05-21	업그레이드	Raymond James	Mkt Perform → Strong Buy
2019-03-20	개시	SunTrust	Buy
2019-03-08	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2018-12-14	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	다운그레이드	SunTrust	Buy → Hold
2018-08-13	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	개시	Morgan Stanley	Overweight
2018-06-22	개시	B. Riley FBR, Inc.	Buy

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Compare AMRX vs TAK, HLN, TEVA, ZTS, UTHR

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Amneal: Kashiv Deal Fuels Biosimilar Growth, But Stock Already Prices In Optimism (AMRX) - Seeking Alpha

Here's why Amneal Pharmaceuticals (AMRX) is a strong growth stock - MSN

Amneal Pharmaceuticals (AMRX) Proxy filing Summary - Quartr

How First-Generic OMNIPAQUE Rivals At Amneal Pharmaceuticals (AMRX) Have Changed Its Investment Story - Sahm

Amneal receives FDA approval for additional iohexol strengths By Investing.com - Investing.com South Africa

Amneal receives FDA approval for additional iohexol strengths - Investing.com

Amneal Pharmaceuticals Receives FDA Approval for Additional Iohexol Injection Strengths and Vial Presentations - Quiver Quantitative

Amneal's FDA-approved contrast options give hospitals more vial choices - Stock Titan

Amneal gains FDA approval for four iohexol products - grafa.com

Amneal Pharmaceuticals stock hits 52-week high at 17.86 USD By Investing.com - Investing.com South Africa

Amneal Pharmaceuticals stock hits 52-week high at 17.86 USD - Investing.com

Is Amneal Pharmaceuticals (AMRX) Fairly Valued After Its Sharp Rerating? - Sahm

Amneal Pharmaceuticals (AMRX) Barclays 28th Annual Global Healthcare Conference summary - Quartr

Amneal Pharmaceuticals stock holds steady as generic pipeline supports long term growth - Ad-hoc-news.de

Amneal schedules July 30 call for second-quarter 2026 results - Stock Titan

Amneal to Report Second Quarter 2026 Results on July 30, 2026 - The Manila Times

Amneals Planned Sterile Facility Creates Opportunity For Aseptic Filling Isolator And Automation Suppliers - Pharmaceutical Online

Enterprise value to revenue forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers - Yahoo Finance

Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kiely John - Moomoo

Did EMA’s Positive Hopledo Ruling Just Shift Amneal Pharmaceuticals' (AMRX) Investment Narrative? - Sahm

Amneal Sues Alembic to Block Copies of Crexont Parkinson’s Drug - Bloomberg Law News

Amneal Pharmaceuticals updates investors on its generics and specialty pipeline. The company focuses - ad-hoc-news.de

$2M from Amneal targets Parkinson's drug costs for patients - Stock Titan

Amneal Pharmaceuticals (AMRX) Gets EU Backing For Hopledo, Is It Fully Priced? - Sahm

Price to sales forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Amneal Pharmaceuticals : New U.S. Sterile Manufacturing Facility Selected for FDA PreCheck Pilot Program - marketscreener.com

Price to book forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Price to earnings forward of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness - Sahm

Lilly, Regeneron selected for US program to review new manufacturing plants faster - Reuters

Amneal to Buy Kashiv for $375M Cash + 28.9M Shares (NASDAQ: AMRX) - Stock Titan

EMA Recommends Approval of Hopledo for Parkinson's Disease - Intellectia AI

Zambon and Amneal Receive Positive CHMP Opinion for Hopledo in Parkinson’s Disease in Europe - Quiver Quantitative

Does Amneal (AMRX) Joining Three Russell 2000 Defensive Indexes Recast Its Risk Profile? - simplywall.st

Amneal Pharmaceuticals, Inc.(NasdaqGS:AMRX) added to Russell 2000 Value-Defensive Index - marketscreener.com

Amneal Pharmaceuticals, Inc.(NasdaqGS:AMRX) added to Russell 2000 Growth-Defensive Index - marketscreener.com

Amneal Pharmaceuticals, Inc.(NasdaqGS: AMRX) added to Russell 2000 Defensive Index - marketscreener.com

Form DEF 14A Amneal Pharmaceuticals Inc Class A For: 26 June - Investing.com UK

2DT Forecast — Price Target — Prediction for 2027 - TradingView

Amneal Pharmaceuticals, Inc. Class A Actuals & Estimates (NASDAQ:AMRX) - TradingView

AMRX Forecast — Price Target — Prediction for 2027 - TradingView

Amneal Pharmaceuticals (AMRX) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Amneal Pharmaceuticals advances after securing FDA clearance for cancer treatment (AMRX) - MSN

Amneal Pharmaceuticals stock hits 52-week high at 16.62 USD - Investing.com

Amneal Pharmaceuticals stock hits 52-week high at 16.62 USD By Investing.com - Investing.com South Africa

Rytvela from Amneal Pharmaceuticals Inc.biosimilar for chronic uveitis care - AD HOC NEWS

Amgen Inc. v. Amneal Pharm. LLC United States Court of Appeals of the Federal Circuit, 2020 945 F.3d 1368, 2020 - Sage Journals

Amneal Pharmaceuticals (AMRX) Stock Could Be 6% Below Fair Value After Its Sharp Rally - Sahm

Amneal (AMRX) agrees to buy Kashiv for $375M cash plus equity and milestones - Stock Titan

Amneal Pharmaceuticals Inc (AMRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

AMRX과 유사한 종목